Madrigal Pharmaceuticals EPS Basic from Accounting Change (Quarterly) Insights

Madrigal Pharmaceuticals, Inc. (MDGL)

436.12 -0.75 (-0.17%) USD | NASDAQ | Feb 20, 16:00

435.20 -0.92 (-0.21%) After-Hours: 20:00

View EPS Basic from Accounting Change (Quarterly) for MDGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Accounting Change (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	--
Eli Lilly & Co.	--
Insmed, Inc.	--
Johnson & Johnson	--
Crinetics Pharmaceuticals, Inc.	--